Search

Search Constraints

You searched for: Author/Creator Blanco, Francisco J.

Search Results

1. A169: Cumulative Long‐Term Safety, Efficacy and Patient‐Reported Outcomes in Children With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept: Up to 7 Years of Treatment. Issue Volume 66:Issue(2014)supplement 3 (March 2014)

4. The Tumor Suppressor ING5 Is a Dimeric, Bivalent Recognition Molecule of the Histone H3K4me3 Mark. Issue 12 (31st May 2019)

7. Predictive modeling of therapeutic response to chondroitin sulfate/glucosamine hydrochloride in knee osteoarthritis. (August 2019)

9. A169: Cumulative Long‐Term Safety, Efficacy and Patient‐Reported Outcomes in Children With Juvenile Idiopathic Arthritis Treated With Intravenous Abatacept: Up to 7 Years of Treatment. Issue 11 (March 2014)